ethyl [1-(3,4-dichlorobenzyl)piperidin-4-ylidene]acetate | 220772-53-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: ethyl [1-(3,4-dichlorobenzyl)piperidin-4-ylidene]acetate
• 英文别名: Ethyl[1-(3,4-dichlorobenzyl)piperidin-4-ylidene]acetate；ethyl 2-[1-[(3,4-dichlorophenyl)methyl]piperidin-4-ylidene]acetate
• CAS: 220772-53-2
• 化学式: C₁₆H₁₉Cl₂NO₂
• 分子量: 328.238
• InChiKey: DKQVUPYVHMJMAW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl [1-(3,4-dichlorobenzyl)piperidin-4-ylidene]acetate 在 platinum(IV) oxide 氢气 作用下， 以 四氢呋喃 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 生成 4-哌啶乙酸,1-[(3,4-二氯苯基)甲基]-,乙基酯
  参考文献：
  名称：

  Cyclic amine derivatives-CCR-3 receptor antagonists

  摘要：

  这项发明涉及某些符合以下式（I）的环胺衍生物，它们是CCR-3受体拮抗剂，包含它们的药物组合物，以及它们的使用方法和制备这些化合物的方法。

  公开号：

  US06339087B1
• 作为产物：
  描述：

  4-哌啶酮 在 sodium hydride 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 ethyl [1-(3,4-dichlorobenzyl)piperidin-4-ylidene]acetate
  参考文献：
  名称：

  Design and synthesis of novel CCR3 antagonists

  摘要：

  As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC50 of 0.0082 muM in the binding assay and 0.0024 muM in the chemotaxis assay. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/s0960-894x(03)00748-0

文献信息

• Cyclic amine derivatives-CCR-3 receptor antagonists
  申请人：Syntex (U.S.A.) LLC

  公开号：US06339087B1

  公开（公告）日：2002-01-15

  This invention relates to certain cyclic amine derivatives of Formula (I) that are CCR-3 receptor antagonist, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.

  这项发明涉及某些符合以下式（I）的环胺衍生物，它们是CCR-3受体拮抗剂，包含它们的药物组合物，以及它们的使用方法和制备这些化合物的方法。
• Cyclic amine derivatives- CCR-3 receptor antagonists
  申请人：Syntex (U.S.A.) LLC

  公开号：US06323223B1

  公开（公告）日：2001-11-27

  This invention relates to certain cyclic amine derivatives of Formula (I) that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.

  这项发明涉及公式(I)的某些环氨基衍生物，它们是CCR-3受体拮抗剂，包含它们的药物组合物，其使用方法以及这些化合物的制备方法。
• Design and synthesis of novel CCR3 antagonists
  作者：Leyi Gong、J.Heather Hogg、James Collier、Robert S. Wilhelm、Carol Soderberg

  DOI：10.1016/s0960-894x(03)00748-0

  日期：2003.10

  As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC50 of 0.0082 muM in the binding assay and 0.0024 muM in the chemotaxis assay. (C) 2003 Published by Elsevier Ltd.